BCRX BioCryst Pharmaceuticals, Inc. Gross Profit Margin

Corporate emblem and logo of BioCryst Pharmaceuticals Inc (BCRX)

While the R&D center aggressively develops its line of oral treatments for orphan diseases, an ethical culture of patient support and a commitment to deep research prevail within BioCryst (BCRX). The gross margin clearly demonstrates a reduction in production pressure, with the current metric standing at 97.70. Patent protection and the complexity of molecular synthesis ensure business stability, effectively blocking the emergence of cheap generics.

biocryst.com (BCRX): Gross Profitability from 07/04/2022 to 11/19/2026

Analytical breakdowns and data insights for company biocryst.com (BCRX)

- market capitalization data:
Summary company analysis:BioCryst Pharmaceuticals - BCRX
Signature product of BioCryst

The stability of BioCryst (BCRX) financial metrics depends directly on the company's ability to monetize its developments in the field of rare immunology. An analysis of the aggregate gross margin, reflecting the profit share after deducting production costs, allows for an assessment of the commercialization efficiency of oral drugs for the treatment of orphan diseases and the degree of cost control during the release of new enzyme inhibitors.

Direct competitors

argenx - Gross Profit Rate|Gross Profitability biontech.de|ABIVAX (ABVX) - Return on Sales by Gross Profit|Gross Margin ADMA|Gross Profit Ratio PTGX|Gross Profitability Immunovant Corp IMVT|Gross Margin Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Gross Profitability|Return on Sales by Gross Profit Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Return on Gross Profit|Aurinia Pharmaceuticals Inc. (AUPH) - Gross Margin|VERA (Vera Corp) - Gross Margin|Dianthus Pharma (DNTH) - Return on Sales by Gross Profit|Gross Profitability Pharvaris Pharma (PHVS)|Gross Margin AbCellera Corp (ABCL)|Gross Margin TRML (Tourmaline Bio Inc)|Return on Sales by Gross Profit precigen.com (PGEN)|PHAR - Gross Profitability|Gross Profit Rate NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio Corp) - Return on Gross Profit|Zenas Corp (ZBIO) - Gross Margin|Return on Gross Profit IMNM|GOSS: Gross Profit Rate|Gross Profitability KalVista Pharma (KALV)|SEPN - Gross Profit Margin|Gross Margin PVLA (pieris.com)|Gross Margin Savara Pharma SVRA|RIGL: Return on Gross Profit|ANAB - Gross Margin|ATXS: Gross Margin|ENGN - Return on Sales by Gross Profit|Return on Gross Profit RAPT|JBIO (Aerovate Therapeutics Inc) - Gross Profit Ratio|Gross Margin ACRS|Return on Gross Profit kyvernatx.com KYTX|Gross Margin TLSA (Tiziana Life Sciences, Ltd.)|Gross Margin Cabaletta Bio CABA|VTYX: Return on Gross Profit|Theratechnologies Inc. (THTX) - Return on Gross Profit|AVTX: Gross Margin|ELDN - Return on Sales by Gross Profit|AGEN (Agenus, Inc) - Gross Margin|Gross Margin Climb Bio, Inc.|Gross Profitability Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Gross Profit Rate|Gross Margin ADAG (Adagene Inc)|IMA - Return on Gross Profit|STTK - Gross Profitability|EQ (equilliumbio.com) - Gross Return on Sales|CNTB: Gross Margin|Immunic Inc (IMUX) - Gross Margin|ATRA (Atara Biotherapeutics Inc) - Gross Margin|Gross Return on Sales IFRX (InflaRx N.V.)|x4pharma.com (XFOR) - Gross Profit Rate|Adicet Bio, Inc. - Gross Return on Sales|Celularity Inc - Return on Gross Profit|Gross Margin INmune Bio Corporation INMB|Barinthus Biotherapeutics - Gross Margin|Kezar Life Sciences, Inc. (KZR) - Return on Gross Profit|SAB Biotherapeutics Inc. (SABS) - Gross Profitability|Return on Gross Profit Akari Therapeutics plc|Gross Profitability enlivex.com|q32bio.com (QTTB) - Return on Sales by Gross Profit|Gross Margin GOVX|Edesa Biotech, Inc. - Gross Return on Sales|iBio Inc - Return on Gross Profit|Gross Margin Carisma Therapeutics CARM|XTLB - Gross Profitability|BOLT (boltbio.com) - Gross Return on Sales|HCWB: Gross Margin|Aptevo (APVO) - Gross Margin|Gross Profitability AIM ImmunoTech|Return on Gross Profit Aditxt (ADTX)|Return on Gross Profit GRI (GRI Bio Corporation)|XORTX - Gross Return on Sales|Gross Margin HIND (Vyome Holdings Inc.)|Gross Profit Rate REVB|Indaptus - Gross Margin|SCNI (Scinai Immunotherapeutics Ltd.) - Gross Return on Sales|CALI: Gross Margin|Affimed NV - Gross Profit Rate|Gross Profitability Allakos Inc.|Gross Margin HOOKIPA Pharma|Gross Profitability IGM Biosciences, Inc. (IGMS)|ITOS - Gross Profit Margin|Gross Margin OCEA (Ocean Bio)|Gross Profit Rate TCBP|THRD - Gross Profitability